MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Immunodeficiency, unspecified (D84.9)

HealthDay 19 June at 12.01 PM

Deadly Strep Bacteria Is Spreading in Japan

A deadly bacterial infection known as streptococcal toxic shock syndrome (STSS) is spreading across Japan, officials in that country report.In March, Japan's National Institute of Infectious Diseases issued its first warning&nbs

Evalytics 01 April at 06.25 PM

HIV Remission in Children: A Hopeful Development

HIV remission in children, characterized by a sustained period of undetectable viral load without the need for antiretroviral therapy (ART), represents a significant breakthrough in pediatric HIV care. This phenomenon, observed in children who have undergone a pause in treatment, offers new insights into the management and potential cure of HIV/AIDS.

Evalytics 11 March at 01.26 AM

HIV Remission in Children: A Hopeful Development

Pediatric HIV remission, marked by prolonged undetectable viral load sans antiretroviral therapy (ART), is a notable advance. This condition, seen in children with treatment pauses, offers fresh perspectives on HIV/AIDS management and potential cure.

Evalytics 19 February at 03.25 PM

Smoking’s effects on the immune system can last years, study finds

The study reveals smoking's lasting impact on the immune system, increasing vulnerability to diseases even after quitting. Despite declining rates, smoking remains the leading cause of preventable deaths in the US. Quitting improves immunity but doesn't fully recover it, emphasizing the importance of cessation.

HealthDay 31 January at 04.46 PM

Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive Conditions

The risk for prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies across immunosuppressive conditions, according to a study published in the Jan. 24 issue of Science Translational Medicine.Yijia Li, M.D., from Harvard Medical School in Boston, and colleagues performed a detailed viro-immunologic analysis of a

HealthDay 11 January at 09.42 PM

Bivalent COVID-19 Shot Effective for Preventing Thromboembolic Events

A bivalent mRNA COVID-19 vaccine after receipt of an original monovalent COVID-19 vaccine is effective for preventing COVID-19-related thromboembolic events, according to research published in the Jan. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Amanda B. Payne, Ph.D., from the